SCHEMBL24312615

SCHEMBL24312615

CCC(=O)OC[C@@H](OCC#N)[C@@H](OC(=O)CC)[C@@H](OC(=O)CC)c1ccc2c(N)ncnn12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24312610 0.86 TDP1 (0.32) —
SCHEMBL24312536 0.85 RIPK1 (0.31) —
SCHEMBL25013954 0.77 — —
SCHEMBL25012471 0.77 — —
SCHEMBL26214112 0.73 — —
SCHEMBL26325704 0.72 — —
SCHEMBL26317664 0.72 RIPK1 (0.33) —
SCHEMBL26317120 0.72 RIPK1 (0.31) —
SCHEMBL26316679 0.72 RIPK1 (0.31) —
SCHEMBL25013997 0.68 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11814406-B2 Compounds and methods for treatment of viral infections GILEAD SCIENCES, INC. (US) 2023-11-14 — — US disclosed
US-20230151043-A1 COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS GILEAD SCIENCES, INC. 2023-05-18 — — US disclosed
US-20220081462-A1 COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS GILEAD SCIENCES, INC. 2022-03-17 — — US disclosed
Send feedback